NewsEvents

Your Yourlocation: Home > Clinical analysis of tiotropium bromide(136310-93-5) in acute exacerbation of chronic obstructive pulmonary disease

To analyze the clinical therapeutic effect of tiotropium bromide(136310-93-5) in the treatment of acute exacerbation of chronic obstructive pulmonary disease, and to provide some theoretical basis for future respiratory treatment. Methods: Eighty patients with acute exacerbation of chronic obstructive pulmonary disease were randomly divided into observation group and control group. Forty patients were randomly divided into observation group and control group. In the course of treatment, the control group of patients to take conventional treatment measures; observation group of patients in the conventional treatment based on the use of tiotropium bromide(136310-93-5) powder inhalation method for 14 days, compared the two groups of patients before and after treatment of lung function indicators and breathing Difficult score. Results: After treatment, the lung function and dyspnea scores of the two groups were improved, and the patients in the observation group were better than the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Tiotropium bromide(136310-93-5) can significantly improve the patient's dyspnea and improve the quality of life of patients with acute exacerbation of chronic obstructive pulmonary disease.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved